Voize, a nursing-focused AI companion platform, has raised $50 million in a Series A round led by Balderton Capital, with participation from existing backers HV Capital, Redalpine, and Y Combinator.
Voize, a nursing-focused AI companion platform, has raised $50 million in a Series A round led by Balderton Capital, with participation from existing backers HV Capital, Redalpine, and Y Combinator.
Three years ago, while working on chip design at Intel, Luminal co-founder Joe Fioti had a realization: even the most advanced hardware is limited if the software that powers it is difficult for developers to use.
Wolters Kluwer Legal & Regulatory has signed an agreement to acquire Libra Technology GmbH, a Berlin-based developer of AI software for legal professionals.
Flatpay — the Danish startup helping small businesses accept card payments — has officially joined Europe’s growing list of fintech unicorns, now valued at €1.5 billion ($1.75 billion) just three years after launch.
Sofinnova Partners, one of Europe’s leading life sciences venture capital firms, has closed Sofinnova Capital XI at €650 million ($750 million) — well above its initial target.
Dialog, the Paris-based startup building AI shopping agents trained on brand-specific data, has raised €3.7 million in Seed funding to accelerate product development and expand across Europe.
Generative AI is now embedded in modern software development — but most companies still struggle to measure how (or whether) it actually improves engineering productivity. Milestone, an Israeli startup, has raised $10 million in seed funding to fix exactly that.
Two teenage founders and a backyard conversation with Paul Graham have led to one of the most ambitious bets in agricultural technology: using AI to design entirely new pesticide molecules. Bindwell, founded in 2024 by 18-year-old Tyler Rose and 19-year-old Navvye Anand, has raised $6 million in seed funding, co-led
Vancouver-based CereCura Nanotherapeutics, a University of British Columbia (UBC) spinout, has secured $1.4 million CAD in seed funding to advance a new approach for treating neurological diseases using lipid nanoparticle (LNP) RNA technology—the same delivery platform that enabled Moderna and Pfizer’s COVID-19 vaccines.
London-based payments platform Zilch has raised more than €150 million ($175 million) in a new mix of debt and equity funding, positioning the company to scale aggressively across the UK and EMEA.
